Yale AIDS Colloquium Series (YACS) - Robert Dubrow
Thursday, October 31, 2013 from 12:00 PM to 1:00 PM (EDT)
The burden of cancer among persons living with HIV/AIDS is substantial due to both impaired immune function and high prevalence of non-HIV cancer risk factors, such as smoking and oncogenic virus infections. Consequently, the two pillars of cancer prevention in this population are restoration of immune function and medical and behavioral interventions to reduce the prevalence of non-HIV cancer risk factors.
Dubrow, Robert, Michael J. Silverberg, Lesley S. Park, Kristina Crothers, and Amy C. Justice. "HIV infection, aging, and immune function: implications for cancer risk and prevention." Current opinion in oncology 24, no. 5 (2012): 506-16.
Sigel, Keith, Juan Wisnivesky, Kirsha Gordon, Robert Dubrow, Amy Justice, Sheldon T. Brown, Joseph Goulet, Adeel A. Butt, Stephen Crystal, David Rimland et al. "HIV as an independent risk factor for incident lung cancer." AIDS (London, England) 26, no. 8 (2012): 1017-25.
Silverberg, Michael J., Bryan Lau, Amy C. Justice, Eric Engels, John M. Gill, James J. Goedert, Gregory D. Kirk, Gypsyamber D'Souza, Ronald J. Bosch, John T. Brooks et al. "Risk of Anal Cancer in HIV-Infected and HIV-Uninfected Individuals in North America." Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 54, no. 7 (2012): 1026-1034.
Robert Dubrow, M.D., Ph.D. is Professor of Epidemiology in the Department of Chronic Disease Epidemiology at Yale School of Public Health. He has been heavily involved in the educational mission of Yale School of Public Health, as well as in research. Dr. Dubrow was chosen by the Classes of 2002, 2007, and 2012 to be Teacher of the Year, and he currently co-Chairs the Yale School of Public Health Accreditation Advisory Committee, which oversees the school's periodic self-study process leading up to the accreditation review by the Council on Education for Public Health in 2014. Throughout his career, the two broad themes of his research have been cancer and HIV, and over the past 5 years, a major focus of his research has been HIV-related malignancies. Dr. Dubrow serves as Chair of the Veterans Aging Cohort Study (VACS) Cancer Core and co-Chair of the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) Malignancy Working Group. Along with Dr. Michael Silverberg at Kaiser Permanente Northern California, he serves as joint PI of an R01 grant entitled Antiretroviral Therapy Strategies to Lower Cancer Risk in HIV-Infected Persons, which analyzes NA-ACCORD data.
Co-sponsored by the Yale School of Public Health, Division of Epidemiology of Microbial Diseases (EMD), the Yale AIDS Colloquium Series (YACS) is an interdisciplinary academic forum which brings together 50-60 faculty, researchers, pre/postdoctoral and international fellows and first year MPH students to discuss topics of HIV/AIDS-related research and policy.
CIRA supports innovative, interdisciplinary research that combines behavioral, social and biomedical approaches, focused on the implementation of HIV prevention and treatment and the elimination of HIV disparities.
When & Where
Center for Interdisciplinary Research on AIDS at Yale University
CIRA is supported by National Institute of Mental Health Grant No. P30MH062294.
Paul D. Cleary, Ph.D., Principal Investigator